New Jersey A 3245: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2022-03-07)

State: New Jersey · Session: 220 · Bill: A 3245

Subjects: PHARMACEUTIC

Sponsors: Lampitt, Pamela R.

View New Jersey A 3245 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.